SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-130221
Filing Date
2021-04-26
Accepted
2021-04-26 06:07:39
Documents
15
Period of Report
2021-04-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d174090d8k.htm   iXBRL 8-K 28735
2 EX-99.1 d174090dex991.htm EX-99.1 746189
3 EX-99.2 d174090dex992.htm EX-99.2 14420
7 GRAPHIC g174090g0425121339234.jpg GRAPHIC 3325
  Complete submission text file 0001193125-21-130221.txt   1097557

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA mnkd-20210422.xsd EX-101.SCH 3093
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnkd-20210422_lab.xml EX-101.LAB 18138
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnkd-20210422_pre.xml EX-101.PRE 11423
8 EXTRACTED XBRL INSTANCE DOCUMENT d174090d8k_htm.xml XML 3409
Mailing Address 30930 RUSSELL RANCH ROAD SUITE 300 WESTLAKE VILLAGE CA 91362
Business Address 30930 RUSSELL RANCH ROAD SUITE 300 WESTLAKE VILLAGE CA 91362 818-661-5000
MANNKIND CORP (Filer) CIK: 0000899460 (see all company filings)

IRS No.: 133607736 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50865 | Film No.: 21851442
SIC: 2834 Pharmaceutical Preparations